Amplia Therapeutics featured in the * Investor Guide, which was distributed in The Australian newspaper this week.
”A reputable reference guide for investors, this issue features 30+ Australian companies that are working at the forefront of health and biotech – an innovative and vibrant sector of which we are proud to be a part of. This is an exciting time for Amplia, as we recruit new patients into the ACCENT trial, while continuing to identify and explore future development opportunities for our FAK inhibitors.I encourage you to take a look at the guide, read our story, and share it with your network. With thanks,Dr John Lambert”
https://issuu.com/armcustompublishing/docs/stockhead_investor_guide_health_and_biotech_2022/15
- Forums
- ASX - By Stock
- ATX
- Valuation- Amplia is a sleeping giant
Valuation- Amplia is a sleeping giant, page-47
Featured News
Add ATX (ASX) to my watchlist
(20min delay)
|
|||||
Last
15.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $42.59M |
Open | High | Low | Value | Volume |
15.0¢ | 15.5¢ | 14.0¢ | $93.83K | 634.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 91379 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.5¢ | 272514 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3366 | 0.150 |
2 | 166379 | 0.145 |
4 | 150257 | 0.140 |
7 | 302037 | 0.135 |
7 | 524730 | 0.130 |
Price($) | Vol. | No. |
---|---|---|
0.150 | 20000 | 1 |
0.155 | 130579 | 2 |
0.160 | 172909 | 2 |
0.170 | 224676 | 2 |
0.175 | 100000 | 1 |
Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |